The links below provide information about AHNS grants being offered to researchers, reports from those already funded, resources sponsored by AHNS or its members, new discoveries in clinical and basic science research pertinent to head and neck cancer along with information about grants from NIH, ACS and other sources.
Congratulations to Past AHNS Award Winners!
AHNS/AAO-HNSF Alando J. Ballantyne Resident Research Pilot Grant
2025 – Maxwell Lee, MD
Entitled Work: Spatial Transcriptomic Analysis of Cutaneous Squamous Cell Carcinoma
2025 – Arushi Gulati, MD
Entitled Work: Development of a Personalized Device for Treatment of Post-Radiation Trismus
2025 -Bui Nguyen, MD, PhD
Entitled Work: Orphan Non-Coding RNAs in Detecting and Targeting Head and Neck Cancers
2024 – Lauran Kazuko Evans, MD, MPH
Entitled Work: Cutaneous Melanoma Margin Detection Via Dynamic Optical Contrast Imaging
2024 – Tolani Olonisakin, MD, PhD
Entitled Work: CXCL14-mediated Immunomodulation and IP-SNSCC Malignant Progression
AHNS Pilot Grant
2025 – Michelle Chen, MD
Entitled work: Development of a Food is Medicine Intervention for Head and Neck Cancer
2024 – Radhika Duggal, MA
Entitled work: Targeting E6/E7 in HPV+ Oropharyngeal Cancer with Therapeutic RNA nanovaccines
AHNS Presidential Award: Defining and Implementing Value-Based Care in Head and Neck Cancer
2025 – Pratyusha Yalamanchi, MD, MBA
Entitled Work: Defining the Denominator in Head & Neck Value-Based Care: Cancer Continuum Cost
AHNS Presidential Award: Understanding Treatment Resistance in Head and Neck Cancer
2025 – Edward Sim, MD
Entitled Work: Dissecting ALOX5AP+ Macrophages as Drivers of HNSCC Anti-PD1 Resistance
2025 -Kazi Ahmed, PhD
Entitled Work: Unlocking PI3K Inhibitors: Predicting Treatment Resistance in Head & Neck Cancer
2024 – Harit Panda, PhD
Entitled Work: Mechanistic insights into Nrf2-Mediated Treatment Resistance in HNSCC
2024 – Hoang Bui Nguyen, MD, PhD
Entitled Work: MXD3 as a Determinant of Immunoproliferative Response to Immunotherapy in HNSCC
AHNS Presidential Award: Novel Therapeutic Targets and Combinations in Head and Neck Cancer
2025 – Jovanka Gencel-Augusto, PhD
Entitled Work: Cholesterol Metabolism as Therapeutic Target in p53-Deficient HNSCC
2024 – Barry A. Kriegsman, MD, PhD
Entitled Work: Evaluating Head and Neck Cancer Therapies using Precision-Cut Tumor Slices cancer
AHNS/AAO-HNSF Young Investigator Research Development Award
2025 – Albert Han, MD, PhD
Entitled Work: Investigating Stroma-Driven Tumor Support Pathways in HPV+ Oropharyngeal Cancer
AHNS ENDOCRINE SURGERY SECTION ThyCa: Thyroid Cancer Survivors’ Association Award for Thyroid Cancer Research Grant
2025 – Taylor Jamil, MD, MPH
Entitled Work: Identification and Validation of Germline Mutations in Thyroid Carcinoma
2024 – Radhika Duggal, MA
Entitled Work: Therapeutic Personalized RNA-LPs for dab/tram-tolerant Anaplastic Thyroid Cancer
Myers’ Summer Travel Fellowship in Otolaryngology for Under-Represented Minority Medical Students
- A personal statement, not more than 500 words (one page, single-spaced) detailing why you want this fellowship experience. Please include in the personal statement your underrepresented minority status
- A copy of your CV to be included with the personal statement
- A letter of recommendation
- Students must be in good standing at an accredited US medical school
The 2025 Myers’ Summer Travel Fellowship Application is now closed!
See Criteria and Apply Here!
Congratulations to the recipients:
2025: Hailie C. Hayes
Medical College of Georgia at Augusta University
MD Candidate, Class of 2027
2024: Gabrianna Andrews
Rowan-Virtua School of Osteopathic Medicine
DO Candidate, Class of 2026
2023: Laura E. Jackson
University of Kansas School of Medicine
MD Candidate, Class of 2026
2022: Priya Arya
Mercer University School of Medicine in Savannah, GA
MD Candidate, Class of 2025
2021: Symone V. Jordan
University of Louisville School of Medicine, Louisville, KY
MD Candidate, Class of 2024
“Parathyroid Carcinoma: An NCDB Analysis to Understand Diagnostic Challenges and
Outcomes of a Rare Endocrine Tumor”
2020: Derrick B. Lewis
Mayo Clinic College of Medicine and Science, Rochester, Minnesota
MD Candidate, Class 2023
“Improving Care for Patients with HPV+ Oropharyngeal Squamous Cell Carcinoma”
2019: Ezinne U. Agwaramgbo
University of Miami Florida, Leonard M. Miller School of Medicine
MD Candidate, Class of 2022
“Determining correlation between point of care and ELISA tests in detecting P16 biomarker protein”
2018: Frantzlee LaCrete
University of Nebraska Medical Center
MD Candidate, Class of 2024